Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
3.910
-0.100 (-2.49%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $21.24 million as of October 31, 2024. Its market cap has increased by 6.73% in one year.
Market Cap
21.24M
Enterprise Value
-5.60M
1-Year Change
6.73%
Ranking
Category
Stock Price
$3.91
Market Cap Chart
Since October 3, 2019, Aprea Therapeutics's market cap has decreased from $393.80M to $21.24M, a decrease of -94.61%. That is a compound annual growth rate of -43.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2024 | 21.80M | 23.86% |
| Dec 29, 2023 | 17.60M | 0.57% |
| Dec 30, 2022 | 17.50M | -71.59% |
| Dec 31, 2021 | 61.60M | -40.88% |
| Dec 31, 2020 | 104.20M | -89.18% |
| Dec 31, 2019 | 963.30M | 144.62% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pluri | 23.63M |
| Unity Biotechnology | 23.59M |
| RenovoRx | 23.51M |
| Nexalin Technology | 23.29M |
| PolyPid | 23.26M |
| Impact BioMedical | 23.00M |
| BioVie | 22.76M |
| Cadrenal Therapeutics | 22.59M |